Variables that impact decisions to initiate therapy for solid tumor cancers versus wait for results of genomic profiling assays. Bruce Feinberg, DO: I asked Kenna. You can't talk for her. Kenna R.

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

See how QIAGEN’s flexible pipetting technologies optimize PCR sample preparation, enabling consistent results and faster ...

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Yet ever since a close family member was diagnosed with Stage 4 renal cell carcinoma back in 2015, it has also been intensely personal. In dealing with docs, nurses, technology, I am routinely ...

The challenge is to give the right drug to the right patient by selecting the most effective therapy and avoiding ineffective, toxic, and expensive treatments. During the last decade, several targeted ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Molecular tests and antigen tests have ...

A diagnostic test developed by a startup in Ribeirão Preto, in the interior of the state of São Paulo, Brazil, helps identify and classify thyroid nodules. The test prevents patients with suspected ...

ROCKVILLE, Md. – March 31, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, and pathologist Michael Laposata , M.D. , Ph.D., today ...